Market segmentation
By Type
- Disposables
- Equipment
- Software
- Services
By Application
- Therapeutic Intervention
- Research
- Development
- Cell
- Gene Therapy Manufacturing
By End User
- Blood Component Providers
- Blood Centers
- Hospital Hematology Departments
- Academic Research Institutions
- Commercial Cell Therapy Manufacturers
By Indication
- Leukemia
- Hepatocellular Carcinoma
- Other Malignancies
Regional analysis
North America sustains the largest market footprint due to its established cell and gene therapy ecosystem, mature hospital infrastructure, and predictable reimbursement pathways for leukapheresis procedures. Asia Pacific emerges as the fastest-growing region at 10.0 percent compound annual growth, fueled by expanding research institutions, rising leukemia incidence among aging populations, and accelerating clinical trial activity in immuno-oncology across China, Japan, and South Korea. Europe maintains steady growth through hospital capability upgrades and decentralized collection network development, while LAMEA regions show emerging potential as investment in blood center infrastructure and cell therapy research programs accelerates, though constrained by healthcare budget limitations and reimbursement variability.
Opportunities to watch
Emerging economies across Asia Pacific, Latin America, and the Middle East are attracting substantial research infrastructure investments and drawing participation from global clinical trial sponsors. Academic medical centers, biotechnology firms, and government health initiatives in these regions are actively expanding leukapheresis capacity to support early-stage immunotherapy trials, particularly CAR-T, TCR, and NK-cell programs that require large-scale cell harvesting and processing.
Leading companies
- Terumo BCT
- Fresenius Kabi
- SCTbio
- Rising incidence and prevalence of leukemia
- Haemonetics Corporation
- Grifols S.A
- Macopharma
- Medica S.p.A
For complete market sizing, forecasts, and competitive intelligence, read the full Leukapheresis Market — covering growth drivers, regional analysis, and leading company profiles through 2033.